Metabolic
1 drug is in development for Metabolism, Inborn Errors.
- Companies
- 1
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Metabolism, Inborn Errors pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nexiguran ziclumeran | Intellia Therapeutics, Inc. (NTLA) |
About this indication
Metabolism, Inborn Errors context
Metabolic·MeSH: Metabolism, Inborn Errors (D008661)
Also known as: Error, Inborn Metabolism, Errors Metabolisms, Inborn, Errors, Inborn Metabolism, Inborn Errors of Metabolism, Metabolism Inborn Error, Metabolism Inborn Errors
Frequently asked questions
How many drugs are in development for Metabolism, Inborn Errors?
BioSniper tracks 1 drug in development for Metabolism, Inborn Errors across 1 company.
How many clinical trials target Metabolism, Inborn Errors?
There are 6 clinical trials targeting Metabolism, Inborn Errors tracked by BioSniper.